Urethralgia and Uroflowmtry Assessment in Patients after Conventional TURP versus PVP

Abstract

B enign prostatic hyperplasia (BPH), is one of the most common diseases of aging men, it can be associated with bothersome lower urinary tract symptoms (LUTS) that affect quality of life. A wide range of treatment methods have been introduced. But when surgical treatment is considered, transurethral resection of the prostate (TURP) is still the gold standard. However TURP still has its share of complications which led to emergence of new minimally invasive techniques to minimize the risks associated with the procedure. The most commonly used of these techniques is the lasers and transurethral vaporization of the prostate Despite the good results and minimal rate of complications associated with lasers the cost of these procedure represent an obstacle to its use worldwide also the steep learning curve of some of these procedures, restricts the technique to rather few centers. Plasma vaporization of the prostate combines the low morbidity and the affordable cost which presents the major drawback of laser procedures, especially when it can achieve similar results to TURP in improving the patient's symptomatology leading to more satisfying International Prostate Symptom Score urinary flow rate and reduction in residual urine volume. In this study plasma vaporization of the prostate was equivalent to conventional monopolar TURP in improvement of IPSS and urinary flow rates at 1and 3 and 6 months of follow-up.